Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: Comparison study among two recombinants and one plasma-derived factor VIII

Haemophilia

Volumn 16, Issue 5, 2010, Pages 740-746

  Takedani, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Continuous infusion; Haemophilia A; Inter product variability; Total joint surgery

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING INHIBITOR; CROSS EIGHT M; RECOMBINANT BLOOD CLOTTING FACTOR 8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BOLUS INJECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE CONTROL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INFUSION; DRUG SAFETY; ELBOW ARTHROSCOPY; HEMOPHILIA A; HIP ARTHROPLASTY; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; THROMBOPHLEBITIS; THROMBOSIS; TOTAL KNEE REPLACEMENT;

ADULT; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FACTOR VIII; HEMOPHILIA A; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PLASMA; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS;

EID: 77955976081     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02244.x     Document Type: Article

References (19)

1. Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery. Br J Haematol 2000, 110:715-20.
2. Bidlingmaier C, Deml MM, Kurnik K. Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections. Haemophilia 2006, 12:212-7.
3. Lee M, Morfini M, Negrier C, Chamouard V. The pharmacokinetics of coagulation factors. Haemophilia 2006, 12(Suppl. 3):1-7.
4. Martinowitz U, Luboshitz J, Bashari D. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia. Haemophilia 2009, 15:676-85.
5. Negrier C, Shapiro A, Berntorp E. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients. Thromb Haemost 2008, 100:217-23.
6. Neidhardt E, Koval R, Burke E, Warne N. In vitro evaluation of B-domain deleted recombinant factor VIII (ReFacto) stability during simulated continuous infusion administration. Haemophilia 2005, 11:319-25.
7. Parti R, Schoppmann A, Lee H, Yang L. Stability of lyophilized and reconstituted plasma/albumin-free recombinant human factor VIII (ADVATE rAHF-PFM). Haemophilia 2005, 11:492-6.
8. Stachnik JM, Gabay MP. Continuous infusion of coagulation factor products. Ann Pharmacother 2002, 36:882-91.
9. Schulman S. Continuous infusion. Haemophilia 2003, 9:368-75.
10. Takedani H, Abe Y, Kajiwara M, Kuwata A. [Intravenous catheter occlusion during continuous infusion of a new recombinant factor VIII concentrate]. [Rinsho ketsueki] Jpn J Clin Hematol 2003, 44:339-41.
11. Brinkhous KM. Hemophilia. Bull N Y Acad Med 1954, 30:325-42.
12. McMillan CW, Webster WP, Roberts HR, Blythe WB. Continuous intravenous infusion of factor VIII in classic haemophilia. Br J Haematol 1970, 18:659-67.
13. Dingli D, Gastineau DA, Gilchrist GS, Nichols WL, Wilke JL. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates. Haemophilia 2002, 8:629-34.
14. Mulcahy R, Walsh M, Scully MF. Retrospective audit of a continuous infusion protocol for haemophilia A at a single haemophilia treatment centre. Haemophilia 2005, 11:208-15.
15. Stieltjes N, Altisent C, Auerswald G. Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience. Haemophilia 2004, 10:452-8.
16. Batorova A, Martinowitz U. Continuous infusion of coagulation factors. Haemophilia 2002, 8:170-7.
17. Henze W, Kellermann E, Larson P, Gorina E. Stability of full-length recombinant FVIII formulated with sucrose during continuous infusion using a mini-pump infusion device. J Thromb Haemost 2005, 3:1530-1.
18. McLeod AG, Walker IR, Zheng S, Hayward CP. Loss of factor VIII activity during storage in PVC containers due to adsorption. Haemophilia 2000, 6:89-92.
19. Fernandez M, Yu T, Bjornson E, Luu H, Spotts G. Stability of ADVATE, antihemophilic factor (recombinant) plasma/albumin-free method, during simulated continuous infusion. Blood Coagul Fibrinolysis 2006, 17:165-71.